Global Healthcare Reimbursement Market : Industry Analysis And Forecast

By Author: shankar hanamghar
Total Articles: 411
Comment this article

Global Healthcare Reimbursement Market was valued at US$ 17.7 Bn in 2018 and is expected to reach US$ 57.8 Bn by 2026, at a CAGR of 16.79% during a forecast period.

Increasing healthcare burden on emerged and emerging economies combined with favourablefavorable regulatory policies and also supportive reimbursement scenario has been key development stimulants for the healthcare reimbursement market. Developing patient volume alongside expanded expense of professionally prescribed prescription are bringing about the weight on people, which is maybe going to goad the development of the market. Similarly, a constant increment in the expense of medicinal services is empowering partner enthusiasm for repayment. Social insurance spending is increasing on the grounds that costs for specialist discussion, treatment, and professionally prescribed medications are seeing growth.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

However, some incidences of fraud related to federal ...
... and state government health care programs may hamper the growth of the healthcare reimbursement market on a global scale.

Private payers dominated the segment in 2018. They are estimated to remain dominant during the forecast horizon because of the fact that a large number of private players are present in the market. Similarly, more than 125 health insurance companies provide private health coverage in the U.S.

Hospital is expected to the leading segment during the forecast period. This can be attributed to the growing geriatric population along with an increasing number of surgeries. Merging hospital systems to cover a large population or geographical area generates more bargaining power to escalate reimbursement.

North America is expected to contribute to the major share in the healthcare reimbursement market in the forecast period. Europe is likely to be the second largest market due to the increase in the public healthcare services provider, better reimbursement policies and coverage policies and others. The Asia Pacific region is anticipated to be the fastest growing region owing to the increasing expenditures by government and initiation of the reimbursement plans for healthcare.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Healthcare Reimbursement Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the Global Healthcare Reimbursement Market.
Scope of the Global Healthcare Reimbursement Market

Global Healthcare Reimbursement Market, by Claim

• Underpaid
• Full Paid
Global Healthcare Reimbursement Market, by Payers

• Private Payers
• Public Payers
Global Healthcare Reimbursement Market, by Service Provider

• Physician office
• Hospital
• Diagnostic Laboratories
• Others
Global Healthcare Reimbursement Market, by Region

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• South America
Key players operating in Global Healthcare Reimbursement Market

• UnitedHealth Group
• Aviva
• Allianz
• CVS Health
• BNP Paribas
• Aetna
• Nippon Life Insurance
• WellCare Health Plans
• AgileHealthInsurance
• The Blue Cross Blue Shield Association